Back to search

Article

Efficacy and Safety of Guselkumab and Adalimumab for Pustulotic Arthro-Osteitis and their Impact on Peripheral Blood Immunophenotypes

2022-06-24

Abstract excerpt

<h4>Objectives: </h4> We compared the treatment effectiveness between guselkumab (GUS) and adalimumab (ADA) in patients with pustulotic arthro-osteitis (PAO). In addition, we performed peripheral blood immunophenotyping to elucidate the immunological background and analyzed the impact of therapeutic drugs to verify the validity of immunological phenotypes as therapeutic targets. <h4>Methods: </h4> Patients were tr...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
ff8e83aa-7dc8-562c-849a-47c5cc8d77ee
DOI
10.21203/rs.3.rs-1771512/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Efficacy and Safety of Guselkumab and Adalimumab for Pustulotic Arthro-Osteitis and their Impact on Peripheral Blood ImmunophenotypesDOI 10.21203/rs.3.rs-1771512/v1
Select a neighboring publication to make it the new centre.